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Background: The major stress-inducible heat shock protein 70 (Hsp70) is frequently overexpressed in the cytosol
and integrated in the plasma membrane of tumor cells via lipid anchorage. Following stress such as non-lethal
irradiation Hsp70 synthesis is up-regulated. Intracellular located Hsp70 is known to exert cytoprotective properties,
however, less is known about membrane (m)Hsp70. Herein, we investigate the role of mHsp70 in the sensitivity
towards irradiation in tumor sublines that differ in their cytosolic and/or mHsp70 levels.
Methods: The isogenic human colon carcinoma sublines CX+ with stable high and CX− with stable low expression
of mHsp70 were generated by fluorescence activated cell sorting, the mouse mammary carcinoma sublines 4 T1
(4 T1 ctrl) and Hsp70 knock-down (4 T1 Hsp70 KD) were produced using the CRISPR/Cas9 system, and the Hsp70
down-regulation in human lung carcinoma sublines H1339 ctrl/H1339 HSF-1 KD and EPLC-272H ctrl/EPLC-272H
HSF-1 KD was achieved by small interfering (si)RNA against Heat shock factor 1 (HSF-1). Cytosolic and mHsp70 was
quantified by Western blot analysis/ELISA and flow cytometry; double strand breaks (DSBs) and apoptosis were
measured by flow cytometry using antibodies against γH2AX and real-time PCR (RT-PCR) using primers and
antibodies directed against apoptosis related genes; and radiation sensitivity was determined using clonogenic cell
surviving assays.
Results: CX+/CX− tumor cells exhibited similar cytosolic but differed significantly in their mHsp70 levels, 4 T1 ctrl/
4 T1 Hsp70 KD cells showed significant differences in their cytosolic and mHsp70 levels and H1339 ctrl/H1339 HSF-1
KD and EPLC-272H ctrl/EPLC-272H HSF-1 KD lung carcinoma cell sublines had similar mHsp70 but significantly
different cytosolic Hsp70 levels. γH2AX was significantly up-regulated in irradiated CX− and 4 T1 Hsp70 KD with low
basal mHsp70 levels, but not in their mHsp70 high expressing counterparts, irrespectively of their cytosolic Hsp70
content. After irradiation γH2AX, Caspase 3/7 and Annexin V were up-regulated in the lung carcinoma sublines, but
no significant differences were observed in H1339 ctrl/H1339 HSF-1 KD, and EPLC-272H ctrl/EPLC-272H HSF-1 KD
that exhibit identical mHsp70 but different cytosolic Hsp70 levels. Clonogenic cell survival was significantly lower in
CX− and 4 T1 Hsp70 KD cells with low mHsp70 expression, than in CX+ and 4 T1 ctrl cells, whereas no difference in
clonogenic cell survival was observed in H1339 ctrl/H1339 HSF-1 KD and EPLC-272H ctrl/ EPLC-272H HSF-1 KD
sublines with identical mHsp70 but different cytosolic Hsp70 levels.
Conclusion: In summary, our results indicate that mHsp70 has an impact on radiation resistance.
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Apart from surgery and chemotherapy, radiotherapy is
one of the three key treatment modalities to treat local-
ized solid tumors. The major goal of therapeutic irradi-
ation is to inflict deleterious damage selectively in tumor
cells. While some cancer cells are directly killed by irradi-
ation, others appear to activate mechanisms of resistance.
Similar to other stress stimuli such as hyperthermia, hyp-
oxia, reactive oxygen species (ROS), heavy metals, cytotoxic
drugs, glucose deprivation also ionizing irradiation induces
a complex stress reaction in the exposed tumor and normal
tissues [1, 2]. Heat shock protein 70 (Hsp70), one of the
major stress-inducible members of the 70 kDa stress pro-
tein family (HSP70) whose expression is mainly regulated
by Heat Shock Factor 1 (HSF-1) consists of at least 8 hom-
ologous members, exerts tumorigenic functions by sustain-
ing proliferative cell signaling, increasing invasive and
metastatic activity and migration and by preventing apop-
totic signaling [3, 4]. Hsp70 is frequently constitutively
overexpressed in the cytosol and present on the plasma
membrane of many different tumor types [5–7] to promote
cancer cell survival, tumorigenicity and anti-apoptotic activ-
ities, such as interfering with the apoptosis signal regulating
kinase 1 (ASK1) and the co-chaperone CHIP [5–11], block-
ing BAX translocation to the mitochondria [12] or by inter-
fering with lysosomal membranes and thereby inhibiting
their permeabilization [13]. Apart from its intracellulat
localization, Hsp70 can be transported to and anchored on
the plasma membrane of tumor, but not normal cells, via
tumor-specific lipid vesicular transport which is not com-
pletely unravelled [14]. Membrane Hsp70-positive tumors
have been shown to actively release Hsp70 in exosomes
[14, 15] that can fuse with the plasma membrane. Since
normal cells do not present Hsp70 on their cell surfaces,
mHsp70 serves as a tumor-specific targeting structure for
in vivo imaging [16, 17], and lipid-bound Hsp70 in the
blood might provide a novel tumor biomarker in liquid bi-
opsies [14, 15].
As mentioned before, cytosolic Hsp70 exerts cytopro-
tective properties by interfering with anti-apoptotic sig-
naling pathways [18]. In mammalian cells, apoptosis can
be caused by either intrinsic or extrinsic pathways [19]
whereby apoptotic factors such as cytochrome c which
are released by mitochondria with a disturbed mem-
brane potential induce the intrinsic pathway [20, 21],
and the binding of extracellular protein death ligands of
the tumor necrosis factor (TNF) family to pro-apoptotic
death receptors (DRs) on the cell surface can initiate the
extrinsic apoptotic cascade [20].
Overexpression of Hsp70 can provide tumor cells with a
selective survival advantage in part due to its ability to in-
hibit multiple pathways of cell death, including both intrin-
sic and extrinsic apoptosis [10, 22, 23]. Hsp70 can bind
directly to the pro-apoptotic Bcl-2 family member BAX,which is part of the intrinsic apoptosis pathway and thus
prevents its activation and translocation to the mitochon-
dria [24, 25]. Hsp70 can also interact with death receptors
DR4 and DR5 of the extrinsic apoptotic pathway and thus
inhibits the assembly of the death-inducing signaling com-
plexes [26]. Therefore, inhibition of cytosolic Hsp70 pro-
vides a promising concept in anti-cancer therapies. It also
has been described that mHsp70-positive tumor cells are
better protected against ionizing irradiation compared to
their mHsp70-negative counterparts [27]. Herein, we want
to study the impact of cytosolic versus mHsp70 in the ra-
diosensitivity of four isogenic tumor cell systems.
Materials and methods
Cells and cell culture
Three human and one mouse carcinoma subline of dif-
ferent origin was used in the study. The size of mouse
carcinoma cells significantly smaller than that of the hu-
man tumor cell lines. The human adeno colon carcin-
oma cell line CX-2 (Tumorzellbank, DKFZ Heidelberg,
Germany) gave rise to the sublines CX+ with a stable
high and CX− with a low mHsp70 expression after fluor-
escence activated cell sorting [27, 28]. The HSF-1
knock-down (HSF-1 KD) and ctrl human lung cancer
cell lines H1339 (small cell lung carcinoma, SCLC) and
EPLC-272H (non-small cell lung carcinoma, NSCLC;
kindly provided by Prof. Rudolf Huber, Dpt. of Pneu-
monology, University Munich, Germany) as well as the
CX+/CX− sublines were cultured in Roswell Park
Memorial Institute (RPMI)1640 medium (GIBCO,
Eggenstein, Germany) supplemented with 10 % v/v
heat-inactivated fetal calf serum (FCS) (PAA, Pasching,
Austria), 1 % v/v antibiotics (100 IU/ml penicillin,
100 μg/ml streptomycin, GIBCO), 2 mM L-glutamine
(GIBCO) and 1 mM sodium pyruvate (GIBCO). All
adherent growing tumor cells were trypsinized for less
than 3 min with trypsin-ethylene diamine-tetra-acetic
acid (EDTA) (GIBCO), and single cell suspensions were
seeded at constant cell densities of 1.5 × 106 cells in
15 ml fresh medium in T-75 ventilated culture flasks
(Greiner, Nuertingen, Germany).
For knock-down of Hsp70 in the lung carcinoma cells
H1339 and EPLC-272H HSF1 RNAi-Ready pSIREN-
RetroQ vectors with a puromycin resistance (BD Bio-
sciences) was used. Target sequence for HSF-1 small
interfering RNA was 5′-TATGGACTCCAACCTGGA-
TAA-3′ [29]. Retroviruses were produced by transfection
of Phoenix cells with pSIREN-RetroQ/HSF1 shRNA
(shHSF1) or pSIREN-RetroQ (control) (kindly provided by
Profs. J. Yaglom and M. Sherman, Boston University School
of Medicine, USA) using Ca-phosphate. Tumor cells were
infected with virus containing supernatants in the presence
of 10 μg/ml polybrene. Selection was performed with 2 μg/
ml puromycin.
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(ATCC®CRL-2539™, American Type Culture Collection,
Manassas, USA) was used to knock-down Hsp70 by the
CRISPR/Cas9 system [17, 30]. The RNA-guided Cas9
nuclease [31], derived from Streptococcus pyogenes was
used to induce specific DSBs in regions of the chromo-
some that are coding for Hsp70 (HSPA1A/B). After
DSBs were introduced to specific loci, damaged DNA
was repaired by non-homologous end joining (NHEJ)
[32] which resulted in shift of the sequence and a
knock-down (KD) of the targeted gene was achieved
[33]. By using this procedure the subline 4 T1 Hsp70
KD was generated which showed a significant but not
complete reduction in cytosolic and mHsp70. As a con-
trol, 4 T1 cells were transfected with a control vector
4 T1 (ctrl). To obtain a complete Hsp70 knock-out a
second and third treatment cycle using the CRISPR/
Cas9 system was necessary [17]. The 4 T1 sublines were
cultured in Roswell Park Memorial Institute 1640
medium (GIBCO, Eggenstein, Germany) supplemented
with 10 % v/v heat-inactivated fetal calf serum (FCS)
(GIBCO), 1 % v/v antibiotics (penicillin-streptomycin,
GIBCO), 2 mM L-glutamine (GIBCO), non-essential
amino acids, and β-mercaptoethanol. All adherent
tumor cells were trypsinized for 5 min with trypsin-
ethylene diamine-tetra acetic acid (EDTA) (GIBCO),
and single cell suspensions were seeded at constant
cell densities of 1.0 × 106 cells in 20 ml fresh medium
in T-75 ventilated culture flasks (Greiner, Nuertingen,
Germany). Following exposure to stress the 4 T1
Hsp70 KD cell line showed a moderate up-regulation
of Hsp70 in the cytosol which was less pronounced
than that of 4 T1 ctrl cells (data not shown).
All tumor cell sublines were routinely checked and de-
termined as negative for mycoplasma contamination.
SDS-PAGE, western blot analysis, ELISA
Cytosolic proteins were obtained as described previously
[1]. Briefly, 2 × 106 cells were lysed in 10 mM Tris-buffered
saline (TBST buffer, pH 7.5) containing 1 % Nonidet P-40
(NP-40; Sigma Aldrich, St. Louis, MO, USA) on ice for
45 min. Non-soluble material was pelleted by centrifugation
at 10,000 g and discarded. Protein concentration was deter-
mined with the bicinchoninic acid method (BCA Protein
Assay Kit; Pierce, Thermo Fisher Scientific Inc., Rockford,
IL, USA). Equal protein amounts (20 μg) were subjected to
the 10 % sodium dodecyl sulfate-polyacrylamide gel (SDS-
PAGE) following a standard protocol [34]. 10 ng and 25 ng
of recombinant Hsp70 protein [35] were loaded as positive
control and for protein quantification. After SDS-PAGE,
the proteins were transferred to nitrocellulose membranes
(Millipore Corp., Bedford, MA, USA) and/or PVDF mem-
branes following a standard protocol [36]. Non-specific
binding of the membranes was blocked with 5 % skim milkin PBS supplemented with 1 % Tween-20. Blots were incu-
bated with the Hsp70 primary antibody (cmHsp70.1, IgG1;
multimmune, Munich, Germany) and a β-actin antibody
(A5316, Sigma-Aldrich) at 4 °C for 14 h. After two washing
steps, membranes were incubated with a secondary anti-
body (goat anti-mouse IgG peroxidase-conjugated; Pro-
mega, Madison, WI, USA) at room temperature for 1 h. All
antibodies were diluted in 1 % skim milk in PBS sup-
plemented with 1 % Tween-20. Immune complexes
were detected using the ECL detection system (Amer-
sham Biosciences, Buckinghamshire, UK). Blots were
imaged digitally (ChemiDoc Touch Imaging System,
Biorad Laboratories, Hercules, CA, USA) and quanti-
fied using Image Lab Software (Biorad Laboratories)
with automatic settings. The absolute amount of
Hsp70 was determined by the ratio of the ß-actin-nor-
malized integrated volumes of bands, related to Hsp70
positive controls with known amounts which were
used as internal standards.
Hsp70 concentrations were verified by ELISA (R&D
systems) in cell lysates following the manufacturer’s rec-
ommendations. Hsp70 concentrations were calculated
relative to the total protein content of each sample.
Irradiation of tumor cells
CX sublines were irradiated with a single dose of 0 Gy
(sham) to 20 Gy, using the Gulmay RS225A irradiation
machine (Gulmay Medical Ltd., Camberley, UK) at a
dose rate of 0.90 Gy/min (15 mA, 200 keV). A dose of
20 Gy was chosen for γH2AX and Caspase 3/7 and
Annexin V assays because concentrations below did not
result in statistically significant results but showed the
same trend. 4 T1, H1339 and EPLC-272H cell sublines
were irradiated with a single dose of 0 Gy (sham) to
6 Gy with same irradiation equipment as used for the
CX sublines.
Flow cytometry of mHsp70
Single cell suspensions of untreated and treated CX, 4 T1,
H1339 and EPLC-272H sublines were collected at different
time-points after irradiation. A sample of 0.4 × 106 cells was
washed once with 10 % FCS in phosphate-buffered sa-
line (PBS) and incubated with fluorescein isothiocyan-
ate (FITC)-conjugated mouse monoclonal antibody
specific for mHsp70 (cmHsp70.1, IgG1; multimmune
GmbH, Munich, Germany) or a FITC-labeled isotype-
matched IgG-negative control antibody (code 345815;
BD Biosciences, NJ, USA) on ice in the dark for
30 min. Only propidium iodide-negative, viable cells
were gated and the mean fluorescence intensity (mfi)
of antibody-bound cells was analyzed by a FACSCali-
bur flow cytometer (Becton Dikinson, Heidelberg,
Germany). The mfi is a relative value of the total in-
tensity of the signal derived from cmHsp70.1-FITC
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the intensity of the signal intensity which is derived by
viable cells stained with an isotype-matched IgG1-
FITC control antibody. Fluorescence data were plotted by
using CellQuest software (Becton Dickinson, Heidelberg,
Germany).
Flow cytometry of үH2AX
DSBs were assessed by using γH2AX (phosphorylated
Histone H2AX) antibody. The single cell suspensions of
either sham irradiated and/or irradiated CX, 4 T1,
H1339 and EPLC-272H sublines were collected 1 h after
irradiation using trypsin and by mechanical disruption.
Single cell suspensions containing 0.6 × 106 cells were
washed in 0.5 ml PBS and fixed with 70 % ethanol/acetic
acid (3:1). Fixed cells were kept at −20 °C for up to two
weeks before analysis. After removal of the fixative, cell
pellets were re-suspended with 1 ml of 0.15 % Triton X-
100 solution and incubated on ice with anti-phospho-
Histone H2AX, Alexa Fluor 488 conjugate (Novus Bio-
logicals). The mfi of cells that did bind the antibody was
analyzed by flow cytometry.
Quantitative analysis of gene expression
48 h after irradiation total RNA was extracted from
cell pellet containing 1.0 × 106 cells of CX or 4 T1 cells
with MasterPureTM RNA Purification Kit (Epicentre,
Madison, USA). The concentration of RNA was mea-
sured by a Nanodrop™ spectrophotometer at 260 nm.
RNA was reversely transcribed into cDNA using High
Capacity cDNA Reverse Transcription Kits (Life Tech-
nologies GmbH, Darmstadt, Germany). The resulting
cDNA was subjected to quantitative RT-PCR using
primers directed towards Caspase 3, Caspase 7, Cas-
pase 8, Caspase 9, BAD and BAX. Actin B (ActB) was
used as a house keeping gene. The reaction mix was
prepared according to the standard protocol of the kit.
RT-PCR was carried out with a LightCycler® 480
(Roche Diagnostics, Mannheim, Germany) with a
standard thermal profile. Transcriptional changes were
calculated with delta Ct method and normalized with
the house keeping gene. Mean values were obtained
from triplicate samples.
Expression of active Caspase 7, phosphorylated (p)BAD
and BAX
Cell lysates (50 μg/ml) were subjected to SDS-PAGE
(12.5 %) and after transfer, membranes [36] were incu-
bated with a primary rabbit-anti-active Caspase 7,
rabbit-anti-phospho-BAD (1:1000; Ser136), and rabbit-
anti-BAX (1:1000; Cell Signaling Technology, Beverly,
MA, USA) antibody. Following washing, the nitrocel-
lulose (NC) membranes were incubated with a horse-
radish peroxidase (HRP) conjugated secondary anti-rabbit IgG and detected using the ECL system, as de-
scribed above.
Flow cytometry of active Caspase 3/7 and Annexin V
Apoptosis was assessed in all tumor sublines using
CellEvent® Caspase 3/7 Green Detection Reagent (Life
Technologies, Darmstadt, Germany). Single cell suspen-
sions of sham irradiated and irradiated tumor cells were
collected 24 and 48 h after irradiation using trypsin and
mechanical disruption. The single cell suspension con-
taining 0.4 × 106 were washed in 1 ml PBS and incubated
with CellEvent® Caspase 3/7 Green Detection Reagent
and SYTOX AADvanced® dead cell stain solution. The
percentage of antibody-bound cells among viable cells
was determined on a flow cytometer.
Apoptosis was determined in CX+/CX− and 4 T1 ctrl/
4 T1 Hsp70 KD tumor sublines also by Annexin V-FITC
staining. After washing with Annexin V binding buffer cells
were incubated with Annexin V-FITC (Roche Diagnostics,
Mannheim, Germany) for 15 min at room temperature.
After another washing step in PBS/10 % v/v FCS and
2.5 mM CaCl2, propidium iodide (PI) was added for 1 min.
Then cells were analyzed on a FACSCalibur flow cytometer
(BD).
Clonogenic cell survival assay
Single cell suspensions were seeded onto 12-well
plates. CX tumor sublines were irradiated with 0, 2, 4,
6, and 10 Gy and 4 T1, H1339, and EPLC-272H tumor
sublines were irradiated with 0, 2, 4, and 6 Gy at the
Gulmay RS225A irradiation machine (Gulamy Medical
Ltd., Cambereley, UK). A dose of 20 Gy resulted in
too few colonies and thus could not be analyzed (data
not shown). Cells were fixed in ice cold methanol after
reaching colonies containing more than 50 cells and
stained with 0.1 % crystal violet. All colonies with
more than 50 cells were counted automatically using a
Bioreader® (Bio-Sys GmbH, Karben, Germany). To cre-
ate a radiation survival curve, the survival fraction at
each radiation dose was normalized to that control
which was sham-irradiated with 0 Gy.
Statistical analysis
Mean value was calculated and presented with standard de-
viation. The Student t-test was used to evaluate the rele-
vance between variables. A p-value of ≤0.05 was considered
as statistically significant.
Results
Comparison of cytosolic and mHsp70 levels in isogenic
tumor sublines
We investigated cytosolic and mHsp70 levels in isogenic
human colon carcinoma sublines CX+/CX−, mouse mam-
mary carcinoma cell lines 4 T1 ctrl/4 T1 Hsp70 knock-
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sublines H1339 ctrl/H1339 HSF-1 KD and EPLC-272H
ctrl/EPLC-272H HSF-1 KD. Figure 1 shows representative
Western blots of tumor cell lysates of all cell lines under
non-stressed conditions using cmHsp70.1 antibody for the
detection of Hsp70. A defined amount of recombinant
Hsp70 protein (10 ng and 25 ng) was loaded onto the gel
for quantification and β-actin was used as a loading control
and for normalization. Although CX+ (36.4 ± 4.8 ng) and
CX− (32.9 ± 5.0 ng) tumor sublines revealed similar cyto-
solic Hsp70 levels (Fig. 1a and c), the tumor sublines
differed significantly in their mHsp70 expression under
non-stressed conditions (sham; Fig. 2a). Following irradi-
ation at 20 Gy the mHsp70 expression was significantly up-
regulated on CX− but not CX+ tumor cells (20 Gy; Fig. 2a).
A lower irradiation dose of 10 Gy showed a similar trend
with respect to the mHsp70 expression on CX− cells but
did not reach statistical significance (data not shown).
No differences in the cytosolic Hsp70 levels were de-
tected in 4 T1 cells that had been transfected with a
control vector (ctrl) versus 4 T1 wild type (WT) cells
(data not shown). A CRISPR/Cas9 Hsp70 knock-down
(4 T1 Hsp70 KD) revealed significantly lower cytosolic
Hsp70 levels than in 4 T1 ctrl (Fig. 1a and b) and 4 T1
WT cells (data not shown), and mHsp70 levels were
significantly higher in 4 T1 ctrl versus 4 T1 Hsp70 KD

































































Fig. 1 Representative Western blot analysis of cytosolic Hsp70 in CX+/CX−
ctrl/EPLC-272H HSF-1 KD (b) tumor sublines under non-stressed conditions
PAGE and blotted onto nitrocellulose membranes. Hsp70 and ß-actin were
secondary antibody, followed by visualization with ECL kit. β-actin and reco
loading control and for normalization. Normalized Hsp70 values of CX+/CX
EPLC-272H ctrl/EPLC-272H HSF-1 KD (d, e) cell lysates, as determined by W
the mean values of n = 3-4 independent experiments. Significance: *p≤ 0.0Following irradiation at 6 Gy the mHsp70 expression
was significantly up-regulated in 4 T1 Hsp70 KD cells
but not in 4 T1 ctrl cells (6 Gy; Fig. 2b). A lower ir-
radiation dose of 4 Gy showed a similar trend but the
values did not reach statistical significance (data not
shown). 4 T1 mouse mammary carcinoma cells
showed lower Hsp70 levels in the cytosol than human
CX+/CX− cells (Fig. 1a). Although the density of
Hsp70 molecules on the cell surface is similar in
mouse and human tumor cells, the mfi appears to be
higher in 4 T1 cells due to their smaller size.
A siRNA knock-down of HSF-1 in H1339 and
EPLC-272H lung carcinoma cells resulted in a sig-
nificant down-regulation of Hsp70 in the cytosol of
these tumor sublines, as determined by Western blot
analysis (Fig. 1d) and ELISA (Fig. 1e). However, the
reduced cytosolic Hsp70 levels induced by HSF-1
knock-down did not affect the mHsp70 levels, under
non-stressed conditions (Fig. 2c and d) and following
irradiation at 6 Gy (Fig. 2d).
Comparison of radiation-induced DNA double strand
breaks (DSBs) in tumor sublines with different cytosolic
and mHsp70 levels
A quantification of the γH2AX foci as a measure for
DSBs was determined by flow cytometry one hour after
















































ctrl HSF-1 KD ctrl HSF-1 KD
(a), 4 T1 ctrl/4 T1 Hsp70 KD (a), H1339 ctrl/H1339 HSF-1 KD, EPLC-272
. 20 μg of cytosolic proteins were administered to each lane of a SDS/
detected using primary antibodies, an appropriate HRP-conjugated
mbinant Hsp70 protein (10 ng, 25 ng; data not shown) were used as
− and 4 T1 ctrl/4 T1 Hsp70 KD (c), H1339 ctrl/H1339 HSF-1 KD and
estern blot analysis (c, d) and ELISA of cell lysates (e). Bars represent
5, **p≤ 0.01, ***p≤ 0.001
sham 6 Gy
   





















































   


































   






























Fig. 2 Mean fluorescence intensity (mfi) of mHsp70 in CX+/CX− cells 48 h after sham (0 Gy) and 20 Gy irradiation (a, n = 3-4), 4 T1 ctrl/4 T1 Hsp70
KD cells after sham (0 Gy) and 6 Gy irradiation (b, n = 3-4), H1339 ctrl/H1339 HSF-1 (c, n = 4) after sham (0 Gy) and EPLC-272H ctrl/EPLC-272H
HSF-1 KD (d, n = 6) after sham (0 Gy) and 6 Gy irradiation. Bars represent the mean values and the corresponding standard error of the mean




















































































































Fig. 3 Mean fluorescence intensity (mfi) of үH2AX foci in CX+/CX− cells 1 h after sham (0 Gy) and 20 Gy irradiation (a), and 4 T1 ctrl/4 T1 Hsp70
KD cells (b), H1339 ctrl/H1339 HSF-1 cells (c), EPLC-272H ctrl/EPLC-272H HSF-1 KD cells (d) 1 h after sham (0 Gy) and 6 Gy irradiation, respectively
(b, c, d). Bars represent the mean values and the corresponding standard error of the mean (SEM) of n = 3 independent experiments. Significance:
*p≤ 0.05, **p≤ 0.01, ***p≤ 0.001
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0 Gy (sham) and 6 Gy, H1339 ctrl/H1339 HSF-1 KD
(Fig. 3c) and EPLC-272H ctrl/EPLC-272H HSF-1 KD
cells (Fig. 3d) with 0 Gy (sham) and 6 Gy. After irradi-
ation a significant increase in γH2AX was observed in
CX− (40.58 ± 6.45 vs. 88.52 ± 14.19, p ≤ 0.01) and 4 T1
Hsp70 KD cells (60.64 ± 15.20 vs. 257.81 ± 32.04, p ≤
0.01), whilst no statistically significant increase was ob-
served in non-irradiated versus irradiated CX+ and 4 T1
ctrl (or WT cells, data not shown) with initially high
mHsp70 expression. The γH2AX mfi values of irradiated
CX+/CX− (20 Gy; p ≤ 0.001) and 4 T1 ctrl/4 T1 Hsp70
KD (6 Gy; p ≤ 0.05) sublines also differed significantly.
γH2AX did not differ significantly in the sublines H1339
ctrl/H1339 HSF-1 KD and EPLC-272H/EPLC-272H
HSF-1 KD that show an identical mHsp70 expression
(Fig. 3c and d). However, significant differences in үH2AX
foci were observed in sham (0 Gy) and irradiated (6 Gy)
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Fig. 4 Percentage of apoptotic cells as assessed by active Caspase 3/7 (a, b
after sham (0 Gy) and 20 Gy irradiation and 4 T1 ctrl/4 T1 Hsp70 KD cells (b
HSF-1 KD cells (f, h) 48 h after sham (0 Gy) and 6 Gy irradiation, respectivel
error of the mean (SEM) of n = 3-4 experiments. Significance: *p≤ 0.05, **pComparison of radiation-induced apoptosis in tumor
sublines with different cytosolic and mHsp70 levels
For measuring radiation-induced apoptosis the percentage
of active Caspase 3/7 positive cells was determined 48 h
after sham (0 Gy) and 20 Gy irradiation of CX+/CX− tumor
cells by flow cytometry (Fig. 4a). After radiation exposure,
the number of apoptotic cells increased in both, CX+
(3.11 % ± 0.06 % vs. 6.70 % ± 0.97 %, p ≤ 0.01) and CX−
(4.16 % ± 0.16 % vs. 16.67 % ± 0.81 %, p ≤ 0.001) cells, but,
the percentage of apoptotic cells after irradiation (20 Gy)
was significantly higher in CX− than in CX+ cells (p ≤
0.001). Fig. 4b shows similar results for the 4 T1 cell system
48 h after irradiation with 6 Gy. Apoptosis was significantly
more pronounced in irradiated (6 Gy) compared to sham
irradiated 4 T1 ctrl cells (0.60 % ± 0.06 % vs. 4.55 % ±
0.54 %, p ≤ 0.01) and 4 T1 Hsp70 KD cells (0.16 % ± 0.06 %
vs. 7.72 % ± 0.21 %, p ≤ 0.001). Compared to irradiated 4 T1
ctrl cells, the percentage of apoptotic cells in 4 T1 Hsp70
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, e, f) and Annexin V (c, d, g, h) staining in CX+/CX− cells (a, c) 48 h
, d), H1339 ctrl/H1339 HSF-1 cells (e, g), EPLC-272H ctrl/EPLC-272H
y. Bars represent the mean values and the corresponding standard
≤ 0.01, ***p≤ 0.001
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with the Annexin V assay in CX+/CX− (Fig. 4c) and 4 T1
ctrl/4 T1 Hsp70 KD (Fig. 4d) tumor cells after sham (0 Gy)
and 20 Gy irradiation and H1339 ctrl/H1339 HSF-1 KD
and EPLC-272H ctrl/EPLC-272H HSF-1 KD cells con-
firmed the results of the Caspase3/7 assay. A radiation dose
of 4 Gy for 4 T1 ctrl/4 T1 Hsp70 KD cells and 10 Gy for
CX+/CX− cells showed a similar trend, however, the data
did not reach statistical significance (data not shown).
In contrast, lung tumor sublines H1339 ctrl/H1339 HSF-
1 KD and EPLC-272H ctrl/EPLC-272H HSF-1 KD with
identical mHsp70 levels did not show significant differences
in apoptosis, as determined by active Caspase 3/7 and
Annexin V positivity under non-irradiated (sham) and irra-
diated (6 Gy) conditions (Fig. 4e and f), although an in-
creased apoptosis was observed following irradiation at
6 Gy in both tumor cell systems.
For further evaluation of radiation-induced changes the
relative gene expression levels of the 4 T1 tumor sublines
were analyzed 1 h after radiation at 0 Gy and 6 Gy. After ir-
radiation, a more than 2-fold up-regulation in the gene ex-
pression of Caspase 3, Caspase 7, and the Bcl-2 subfamily
members BAD (BH3) and BAX (Bcl-2-like protein 4) was
observed in the mHsp70 low expressing 4 T1 Hsp70 KD
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Fig. 5 Apoptosis related gene expression of Caspase 3, Caspase 7, Caspase
in sham (0 Gy) and 6 Gy irradiated 4 T1 ctrl/4 T1 Hsp70 KD cells (a) 1 h afte
standard error of the mean (SEM). Significance: *p≤ 0.05. Protein expression
shown) were determined 24 h after sham (0 Gy) and 6 Gy irradiation in 4 TSignificant differences in the gene expression ratios be-
tween 4 T1 ctrl and 4 T1 Hsp70 KD cells were observed
for Caspase 7 (0.9-fold vs.3.3-fold, p ≤ 0.05), BAX (1.1-fold
vs. 2.5-fold, p ≤ 0.05) and BAD (0.7-fold vs. 2.0-fold, p ≤
0.05). No differences in the gene expression analysis were
observed in 4 T1 ctrl cells that had been transfected with a
control vector versus 4 T1 WTcells (data not shown).
Due to their higher radiation-resistance no significant
changes in apoptosis regulated gene expression was ob-
served in CX+ and CX− cells after irradiation with 20 Gy
(data not shown). However, also in these tumor sublines,
CX− cells with the lower mHsp70 expression showed an
increased expression in Caspase 3/7, BAD and BAX
compared to CX+ cells.
With respect to the levels of apoptosis related pro-
teins differences were observed in phosphorylated
(p)BAD (Fig. 5b) and active Caspase 7 (Fig. 5c), as de-
termined by Western blot analysis. The amount of
anti-apoptotic pBAD decreased in 4 T1 Hsp70 KD
cells 24 h after irradiation at 6 Gy, but not in 4 T1 ctrl
cells, and active Caspase 7 was found to be up-
regulated following irradiation in 4 T1 Hsp70 KD
cells, but not in 4 T1 ctrl cells. No significant differ-
ences were observed in the amount of the cytosolic



























8, Caspase 9, BAD and BAX were analyzed using a quantitative RT-PCR
r irradiation. Bars represent the mean values and the corresponding
of phosphorylated (p)BAD (b), active Caspase 7 (c) and BAX (data not
1 ctrl/ 4 T1 Hsp70 KD (b). Significance: *p = 0.05
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cance was found in the CX+/CX− tumor sublines.
Comparison of radiation-induced changes in the
clonogenic cell survival in tumor sublines with different
cytosolic and mHsp70 levels
Radiation sensitivity of CX (Fig. 6a), 4 T1 (Fig. 6b),
H1339 (Fig. 6c) and EPLC-272H (Fig. 6d) tumor sublines
was assessed in clonogenic cell survival assays. Data
were fitted by the linear quadratic model (Y = (αD
+ βD2) to describe the cell survival following irradiation.
In line with the data obtained by the apoptosis assays
(Fig. 4a), the CX+ cell line, which shows a higher
mHsp70 expression than the CX− cell line, was signifi-
cantly more radiation-resistant at 2 Gy (p ≤ 0.05), 4 Gy
(p ≤ 0.01), and 6 Gy (p ≤ 0.05), respectively. Despite
differences in the mHsp70 expression density, CX+ and
CX− tumor sublines did not differ in their cytosolic
Hsp70 levels (Fig. 1). The α/β ratio was 9.67 for CX+
(D50 = 2.09 Gy) and 35.9 for CX
− (D50 = 1.45 Gy).
Figure 6b shows the results of colony forming assays
for 4 T1 ctrl and 4 T1 Hsp70 KD tumor cells. In line
with the data of the apoptosis assay shown in Fig. 4b,
4 T1 Hsp70 KD cells which do express very little Hsp70
in the cytosol under non-stressed conditions and exhib-
ited a lower expression density on the membrane were
significantly more radiation-sensitive than 4 T1 ctrl at
each individual radiation dose (p ≤ 0.001, p ≤ 0.001 and
p ≤ 0.001 in 2, 4, and 6 Gy, respectively). The α/β ratio
was 0.6 for 4 T1 ctrl (D50 = 3.6 Gy) and 4.3 for 4 T1
Hsp70 KD (D50 = 1.9 Gy). No significant difference in ra-
diation sensitivity was observed when clonogenic celldose [Gy]





































Fig. 6 Clonogenic cell survival data of CX+/CX− cells (a), (n= 8) following irradia
H1339 ctrl/H1339 HSF-1 cells (c), (n= 4), EPLC-272H ctrl/EPLC-272H HSF-1 KD ce
*p≤ 0.05, **p≤ 0.01, ***p≤ 0.001survival was compared in 4 T1 ctrl cells that were trans-
fected with a control vector and 4 T1 WT cells (data not
shown).
H1339 and EPLC-272H lung carcinoma cells and their
mHsp70 identical HSF-1 KD counterparts did not show
any significant differences in clonogenic cell survival
(Fig. 6c and d) despite significant differences in their
cytosolic Hsp70 levels.
Discussion
Radiotherapy plays a central role in the therapy of solid
tumors, either as a single treatment modality or in com-
bination with surgery or systemic chemotherapy. How-
ever, therapeutic outcome is limited due to radiation-
resistant tumor cell clones. Therefore, a better under-
standing of the biological mechanisms which are in-
volved in radiation resistance of tumor cells might
improve the outcome of clinical radiotherapy. Several
biomarkers such as EpCAM [37], mutated p53 [38] or
Bcl-2 [39] have been investigated which were found to
be associated to radiation sensitivity.
Hsp70 the major stress-inducible member of the
HSP70 family [40] is rapidly up-regulated when cells ex-
perience stress, such as ionizing radiation, cytostatic
compounds, heat and hypoxia, nutrient deficiency or
any other stressful events [41–43]. It is important to
note that high cytosolic levels of Hsp70 are frequently
found in cancer cells even under physiological, non-
stressed conditions [8, 22] and that an increased Hsp70
expression correlates with tumor progression, metasta-
sis, resistance to cytostatic drugs and poor prognosis
[8, 40, 41]. Hsp70 plays important roles in the protectiondose [Gy]





































tion at 4 Gy, 6 Gy and 10 Gy and 4 T1 ctrl/4 T1 Hsp70 KD cells (b), (n= 3),
lls (d), (n= 4) following irradiation at 2, 4 and 6 Gy, respectively. Significance:
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with apoptosis pathways downstream of the execution
protease caspase-3-like [10], and as an inhibitor of apop-
tosis by the recruitment of pro-caspase 9 and binding to
the apoptosome Apaf-1 [44, 45]. Together with its co-
chaperone CHIP, Hsp70 can block TNFα-induced apop-
tosis through the formation of a complex consisting of
Hsp70/CHIP and the apoptosis signal-regulating kinase
1 ASK1 [11, 46]. Furthermore, Hsp70 can inhibit the
translocation of the pro-apoptotic molecule BAX to
mitochondria [12]. A translocation and anchorage of
Hsp70 into lysosomal membranes also has been found
to promote tumor cell survival by stabilization of lyso-
somal membranes [22, 47]. In collaboration with the
group of Jäättelä, we could show that tumor cells that do
present Hsp70 on their plasma membrane also exhibit
Hsp70 in their lysosomal membranes and thus are better
protected towards apoptotic stimuli such as irradiation
[22]. As shown previously, Hsp70 is transported to the
plasma membrane via a non-classical ER/Golgi transport
pathway, since inhibitors of this pathway such as Brefel-
din A or Monensin did not block Hsp70 plasma mem-
brane expression [5]. These findings are in line with
earlier work of Hightower and Guidon [48] who have
shown an ER-independent release of Hsp70 from viable
cells with intact cell membrane. Similar to Hsp70 other
molecules lacking a secretory signal such as IL1-α, IL-
1β, HMGB1 are described to be exported and imported
in a similar way [49]. The work of Jäättelää et al. [22]
and our own data [17, 50] demonstrate a localization of
Hsp70 in lysosomal membranes and endosomes. There-
fore, we speculate that Hsp70 might be transported to
the plasma membrane via fusion of Hsp70 carrying lipid
vesicles with the plasma membrane. Potential lipid can-
didates which have been proven to interact with recom-
binant Hsp70 are phosphatidylserine PS and the lipid
raft component globoyltriaosylceramide Gb3 [35, 51].
Furthermore, Hsp70 and peptides derived thereof have
been found to be able to cross membranes of living tumor
cells by the involvement of lipid rafts and endocytosis-
dependent/independent mechanisms [16, 52, 53]. There-
fore, it was assumed that after interaction of cytosolic
Hsp70 with lipid vesicles containing PS or Gb3, Hsp70 can
interact with these vesicles in the cytosol. After fusion of
these vesicles with the plasma membrane, Hsp70 gets inte-
grated into the plasma membrane.
Vice versa the fluorescently labelled antibody
cmHsp70.1 which binds to mHsp70 on viable tumor
cells translocates from the plasma membrane into
early endosomes and lysosomes [17]. We hypothesize
that this Hsp70-vesicle mediated translocation is re-
versible and also can occur from the cytosol to the
membrane. Regarding these later findings herein, we
asked the question as to whether plasma mHsp70 isassociated with resistance of tumor cells to apoptotic
cell death and thus might negatively affect sensitivity
of tumor cells towards radiation [5].
Screening of more than 1000 primary human tumor
biopsies and the corresponding normal tissues revealed
that human carcinomas, but none of the tested corre-
sponding normal tissues, frequently present Hsp70 on
their cell surface [5–7]. Functionally, mHsp70 serves as
a tumor-specific target structure for cells of the innate
immune system, especially Natural Killer (NK) cells that
had been activated with Hsp70 peptide TKD plus low
dose IL-2. Furthermore, Hsp70 stabilizes cell membranes
under stress and acts cytoprotective against apoptosis in-
ducing mechanisms [13, 22, 54].
Although cytosolic Hsp70 has been described to exert
cytoprotective properties against irradiation [27] only lit-
tle is known about the role of mHsp70 in the Hsp70-
mediated radiation resistance. It has been shown that
mHsp70-positive tumor cells are better protected against
ionizing irradiation compared to their mHsp70-negative
counterparts [27]. A better understanding of the Hsp70
associated pathways which contribute to the develop-
ment of radiation resistance might stimulate novel strat-
egies to increase the radiation sensitivity of tumor cells.
To address this research question three human and
one mouse isogenic tumor cell system that differed not
only in their cytosolic but also in their mHsp70 levels
were analyzed comparatively. Although CX+ tumor cells
exhibited significantly higher mHsp70 expression levels
than CX− cells their cytosolic Hsp70 were similar
[27, 28]. In contrast, the CRISPR/Cas9 Hsp70 knock-
down mouse mammary carcinoma cell line 4 T1 did
only express low levels of Hsp70 on the plasma mem-
brane and in the cytosol, while 4 T1 ctrl and WT cells
exhibited a strong membrane and cytosolic expression
[17]. To further analyze the impact of mHsp70 in radi-
ation resistance, Hsp70 was down-regulated in two lung
carcinoma cells by a siRNA HSF-1 KD. In contrast to
the CRISPR/Cas9 Hsp70 KD, an HSF-1 KD resulted in a
significant decrease in cytosolic Hsp70 levels whilst
mHsp70 expression remained unaffected.
Among other assays, of radiation-induced the meas-
urement DSBs is an important endpoint for investigating
radiation sensitivity because DSBs potentially lead to cell
death if they are not repaired properly before start of the
next cell division [55, 56]. The phosphorylation of H2A
Histone family, member X (H2AX) on serine 139 which
is then termed γH2AX provides a sensitive marker for
DSBs. Since tumor sublines with low or missing mHsp70
expression in both isogenic cell systems (CX−, 4 T1
Hsp70 KD) showed higher γH2AX fluorescence inten-
sities than their high mHsp70 expressing counterparts,
irrespectively of their cytosolic Hsp70 levels we specu-
late that mHsp70 might be involved in the protection of
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tumor sublines with identical mHsp70 expression but
different cytosolic Hsp70 levels did not show differences
in their γH2AX values.
Radiation-induced apoptosis was analyzed using acti-
vated Caspase 3/7 antibodies and Annexin V in flow cy-
tometry in the non-irradiated and irradiated tumor
sublines. In line with the results of the үH2AX assay,
significantly more apoptotic cells were found in irradi-
ated tumor cells with a low mHsp70 expression, whereas
tumor sublines with identical mHsp70 levels did not dif-
fer in apoptosis, despite differences in their cytosolic
Hsp70 levels.
Apoptosis can be induced either by an intrinsic or ex-
trinsic pathway. Both pathways depend on the initiator
Caspases 2, 8, 9 and 10 and the effector Caspases 3, 6
and 7. The intrinsic pathway of apoptosis gets activated in
response to various noxious stimuli, such as radiation-
induced DNA damage. The balance between pro- and
anti-apoptotic Bcl-2 proteins controls the permeability of
the outer mitochondrial membrane [57]. BAX and BAD
are both pro-apoptotic members of the Bcl-2 family and
mediate the release of cytochrome c from the mitochon-
dria and thus induce the intrinsic apoptotic pathway [58].
In the current study, gene expression analysis was per-
formed with representative initiator Caspases 8, 9 and
effector Caspases 3 and 7 and the pro-apoptotic mole-
cules BAD and BAX. Following irradiation, only Hsp70
KD cells lacking Hsp70 in the cytosol and on the plasma
membrane showed a significant up-regulation of effector
Caspases 3, 7 and BAD and BAX. These data point to-
wards a dependency of the intrinsic apoptotic pathway
on cytosolic and mHsp70 following radiation-induced
DNA damage. Although not reaching statistical signifi-
cance a similar trend could be seen in the isogenic
CX+/CX− cell system. Previous findings of Gotoh and
Stankiewicz [24, 25] showed that Hsp70 can block
stress-induced apoptosis primarily by inhibiting the
activation of BAX. In the absence of cytosolic Hsp70,
BAX might be activated and thus could stimulate
apoptosis. Despite differences in the BAX gene ex-
pression the cytosolic BAX protein levels did not dif-
fer significantly in the tested tumor sublines.
Traditionally, cellular radiation sensitivity is mea-
sured using the clonogenic cell survival assay as the
gold standard. In line with the results of the DSB re-
pair and apoptosis assays, the clonogenic cell survival
was also significantly lower in tumor sublines with a
low mHsp70 expression, irrespectively of their intra-
cellular Hsp70 levels. These data also correspond well
with the findings of Gehrmann et al. who showed that
high mHsp70 expressing tumor cells are better pro-
tected against ionizing irradiation compared to their
low mHsp70 expressing counterparts [27]. Moreover,patients with membrane Hsp70-positive tumors have
shown a significantly decreased overall survival com-
pared to those with mHsp70-negative tumors [59].
Our current study demonstrates that a reduction of
the amount of mHsp70 might improve the possibility to
induce apoptosis through the intrinsic apoptotic pathway
after X-ray irradiation. This finding is in line with previ-
ous reports showing that chemotherapy and radiother-
apy predominantly initiate apoptosis through the
intrinsic pathway [20]. By using an HSF-1 KD system
which down-regulates cytosolic but not mHsp70 levels
we could demonstrate that mHsp70 but not cytosolic
Hsp70 levels have an impact on the radiation sensitivity
of tumor cells. This is an important finding for the de-
velopment of novel radiotherapy strategies for the treat-
ment of radiation resistant tumor cells. Future studies
assessing radiation-sensitization with inhibitors of the
vesicular transport of Hsp70 to the plasma membrane of
tumor cells could be taken into account. Furthermore,
the mHsp70 status which could be determined in the
serum of patients using a novel ELISA detecting liposo-
mal Hsp70 which is actively released by mHsp70 positive
viable tumor cells [60] might provide a useful tool to
predict the radiation sensitivity of tumors over time. We
have shown previously that the majority of Hsp70 found
in the circulation of tumor patients is actively released
in lipid vesicles. Patients with inflammatory diseases
have significantly lower serum Hsp70 levels than tumor
patients [61]. In these patients Hsp70 is released as a free
protein which is predominantly derived from dying cells.
Therefore, we speculate that significantly elevated Hsp70
serum levels which are detectable by the novel lipHsp70
ELISA [59] might have diagnostic/prognostic value.
Conclusion
The results of this study indicate that not only cytosolic
but also mHsp70 has an impact on radiation sensitivity.
Thus, mHsp70 expression is associated with defined var-
iations in the regulation of survival pathways in response
to radiation. The expression of mHsp70 on tumor cells
should be considered as potential new biomarker to
identify radiation-resistance of tumor cells.
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